Yen‐Yi Lin

802 total citations
20 papers, 372 citations indexed

About

Yen‐Yi Lin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Yen‐Yi Lin has authored 20 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Immunology. Recurrent topics in Yen‐Yi Lin's work include Prostate Cancer Treatment and Research (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immunotherapy and Immune Responses (4 papers). Yen‐Yi Lin is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immunotherapy and Immune Responses (4 papers). Yen‐Yi Lin collaborates with scholars based in Canada, United States and United Kingdom. Yen‐Yi Lin's co-authors include Colin C. Collins, Anne Haegert, Ilana Perelshtein, Aharon Gedanken, Tzanko Tzanov, Urs O. Häfeli, Stéphane LeBihan, Javier Hoyo, Horacio Bach and Gethin Owen and has published in prestigious journals such as Bioinformatics, Cancer Research and Scientific Reports.

In The Last Decade

Yen‐Yi Lin

16 papers receiving 370 citations

Peers

Yen‐Yi Lin

PRM

ONCOL

Monika Toporkiewicz Poland

Yuhao Xie China

Qinyi Zhang China

Tao Wan China

Mahsa Akbari Oryani Iran

Ziyu Ye China

Xiaonan Qiu China

Yufan Xiang China

Feifei Song China

Zhirui Zhang China

Monika Toporkiewicz Poland

Yen‐Yi Lin

231 ×1.4

103 ×0.9

42 ×0.5

PRM

84 ×1.4

58 ×1.2

ONCOL

Citations per year, relative to Yen‐Yi Lin Yen‐Yi Lin (= 1×) peers Monika Toporkiewicz

Countries citing papers authored by Yen‐Yi Lin

Since Specialization

Citations

This map shows the geographic impact of Yen‐Yi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yen‐Yi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yen‐Yi Lin more than expected).

Fields of papers citing papers by Yen‐Yi Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yen‐Yi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yen‐Yi Lin. The network helps show where Yen‐Yi Lin may publish in the future.

Co-authorship network of co-authors of Yen‐Yi Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yen‐Yi Lin. A scholar is included among the top collaborators of Yen‐Yi Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yen‐Yi Lin. Yen‐Yi Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Yen‐Yi, et al.. (2025). scMUSCL: multi-source transfer learning for clustering scRNA-seq data. Bioinformatics. 41(5).

Lin, Yen‐Yi, et al.. (2025). PD-1/PD-L1 Cancer Immunotherapeutics Reshape Tumor Microenvironment – Clinical Evidence and Molecular Mechanisms for AI-based Precision Medicine. Clinical Reviews in Allergy & Immunology. 68(1). 91–91.

Kang, Ning, Hui Xue, Nelson K.Y. Wong, et al.. (2025). Exploring B7-H4’s Role in Prostate Cancer Dormancy after Androgen Deprivation Therapy: Extracellular Matrix Interactions and Therapeutic Opportunities. Molecular Cancer Research. 23(4). 327–338.

Liu, Liangliang, Dong Lin, Yuchao Ni, et al.. (2025). CXCR4-LASP1-G9a-SNAIL axis drives NEPC transdifferentiation via induction of EMT and downregulation of REST. Cell Genomics. 5(8). 100916–100916.

Lin, Yen‐Yi, et al.. (2024). Phenotype prediction from single-cell RNA-seq data using attention-based neural networks. Bioinformatics. 40(2). 8 indexed citations

Munro, Lonna, Cheryl G. Pfeifer, Anne Haegert, et al.. (2024). A diversity of novel type-2 innate lymphoid cell subpopulations revealed during tumour expansion. Communications Biology. 7(1). 12–12. 4 indexed citations

Kang, Ning, Hui Xue, Yen‐Yi Lin, et al.. (2023). Influence of ADT on B7-H3 expression during CRPC progression from hormone-naïve prostate cancer. Cancer Gene Therapy. 30(10). 1382–1389. 6 indexed citations

Hsu, Sheng‐Chieh, Ching‐Yu Lin, Yen‐Yi Lin, et al.. (2022). TEAD4 as an Oncogene and a Mitochondrial Modulator. Frontiers in Cell and Developmental Biology. 10. 890419–890419. 22 indexed citations

Wong, Nelson K.Y., Xin Dong, Yen‐Yi Lin, et al.. (2022). Framework of Intrinsic Immune Landscape of Dormant Prostate Cancer. Cells. 11(9). 1550–1550. 2 indexed citations

10.

Shrestha, Raunak, Marta Llauradó Fernández, Amy Dawson, et al.. (2021). Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability. Cancer Research. 81(7). 1681–1694. 26 indexed citations

11.

Mizuno, Kei, Yen‐Yi Lin, Xin Li, et al.. (2021). Establishment and characterization of a novel treatment‐related neuroendocrine prostate cancer cell line KUCaP13. Cancer Science. 112(7). 2781–2791. 16 indexed citations

12.

Slavin, Yael N., Kristina Ivanova, Javier Hoyo, et al.. (2021). Novel Lignin-Capped Silver Nanoparticles against Multidrug-Resistant Bacteria. ACS Applied Materials & Interfaces. 13(19). 22098–22109. 108 indexed citations

13.

Shrestha, Raunak, Robert H. Bell, Yen‐Yi Lin, et al.. (2020). Identification of gene signature for treatment response to guide precision oncology in clear-cell renal cell carcinoma. Scientific Reports. 10(1). 2026–2026. 16 indexed citations

14.

Lin, Yen‐Yi, et al.. (2020). CircMiner: accurate and rapid detection of circular RNA through splice-aware pseudo-alignment scheme. Bioinformatics. 36(12). 3703–3711. 10 indexed citations

15.

Gordon, Jacob A., Ankur Midha, Fatemeh Derakhshan, et al.. (2019). Upregulation of Scavenger Receptor B1 Is Required for Steroidogenic and Nonsteroidogenic Cholesterol Metabolism in Prostate Cancer. Cancer Research. 79(13). 3320–3331. 46 indexed citations

16.

Gawronski, Alexander, Michaël Uhl, Yajia Zhang, et al.. (2018). MechRNA: prediction of lncRNA mechanisms from RNA–RNA and RNA–protein interactions. Bioinformatics. 34(18). 3101–3110. 43 indexed citations

17.

Lin, Yen‐Yi, Phineas T. Hamilton, S. Cenk Şahinalp, et al.. (2017). Mutational Analysis of Gene Fusions Predicts Novel MHC Class I–Restricted T-Cell Epitopes and Immune Signatures in a Subset of Prostate Cancer. Clinical Cancer Research. 23(24). 7596–7607. 17 indexed citations

18.

Lin, Yen‐Yi, et al.. (2017). Discovery and genotyping of novel sequence insertions in many sequenced individuals. Bioinformatics. 33(14). i161–i169. 21 indexed citations

19.

Li, Yinan, Ruiqi Chen, Mary Bowden, et al.. (2017). Establishment of a neuroendocrine prostate cancer model driven by the RNA splicing factor SRRM4. Oncotarget. 8(40). 66878–66888. 19 indexed citations

20.

Dao, Phuong, Ibrahim Numanagić, Yen‐Yi Lin, et al.. (2013). ORMAN: Optimal resolution of ambiguous RNA-Seq multimappings in the presence of novel isoforms. Bioinformatics. 30(5). 644–651. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact